España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Biolase Inc COM PAR $.001 NEW
BIOL
OTC
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.1290
At close: Oct 2, 3:46 PM EDT
Get Report
Comment
Biolase Inc COM PAR $.001 NEW (BIOL) Forecast
News
Earnings
Biolase Inc COM PAR $.001 NEW (BIOL) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Biolase Inc COM PAR $.001 NEW (OTC:BIOL) Stock
Biolase Inc COM PAR $.001 NEW Stock (OTC: BIOL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, October 02, 2024
Benchmark Reiterates Speculative Buy on Biola...
Benzinga Newsdesk
Tuesday, September 03, 2024
Ascendiant Capital Maintains Buy on Biolase, ...
Benzinga Newsdesk
Monday, August 12, 2024
Benchmark Reiterates Speculative Buy on Biola...
Benzinga Newsdesk
Wednesday, June 19, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, June 18, 2024
Biolase shares are trading lower after the co...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
BIOLASE To Delist from Nasdaq
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Tuesday, May 14, 2024
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Benchmark Reiterates Speculative Buy on Biola...
Benzinga Newsdesk
Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, May 13, 2024
Biolase shares are trading higher after the c...
Benzinga Newsdesk
Biolase Q1 2024 Adj EPS $(0.36) Misses $(0.17...
Benzinga Newsdesk
Thursday, April 11, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Wednesday, April 10, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Monday, April 01, 2024
Ascendiant Capital Maintains Buy on Biolase, ...
Benzinga Newsdesk
Friday, March 22, 2024
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Benchmark Maintains Speculative Buy on Biolas...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Dow Dips 200 Points; Nike Shares Fall After Q3 Results
Avi Kapoor
Why BIOLASE Shares Are Surging Friday
Lekha Gupta
US Stocks Edge Lower; FedEx Posts Upbeat Earnings
Avi Kapoor
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Biolase shares are trading higher after the c...
Benzinga Newsdesk
Thursday, March 21, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Biolase Anticipates Q1 Net Revenue To Exceed ...
Benzinga Newsdesk
Biolase shares are trading higher after the c...
Benzinga Newsdesk
Recap: Biolase Q4 Earnings
Benzinga Insights
Biolase Q4 EPS $(1.76) Beats $(2.55) Estimate...
Benzinga Newsdesk
Earnings Scheduled For March 21, 2024
Benzinga Insights
Wednesday, March 20, 2024
Earnings Preview For Biolase
Benzinga Insights
Friday, March 01, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, February 22, 2024
BIOLASE, Inc. Launched Its State-of-the-art A...
Benzinga Newsdesk
Tuesday, February 13, 2024
Nasdaq Down Over 2%; Marriott Earnings Top Views
Avi Kapoor
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Gold Down Over 1%; Coca-Cola Posts Upbeat Sales
Avi Kapoor
Biolase shares are trading lower after the co...
Benzinga Newsdesk
Dow Dips Over 300 Points; US Annual Inflation Slows to 3.1% In January
Avi Kapoor
BIOLASE, Inc. Announces Pricing Of $7M Public...
Benzinga Newsdesk
Friday, February 09, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Top 5 Health Care Stocks That Are Preparing To Pump In February
Avi Kapoor
Wednesday, February 07, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Tuesday, February 06, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Wednesday, January 31, 2024
Biolase Filed For Offering On A Best Efforts Basis Up To 8.8M Units
Charles Gross
Monday, January 29, 2024
Biolase Expects Full-Year 2024 Revenue Of $52...
Benzinga Newsdesk
Biolase Reports Full-year 2023 Interim Revenu...
Benzinga Newsdesk
Show More